CLLS 6-K: SEC filing

Cellectis S.A.

Filed with the SEC on · accession 0001171843-26-007273

CLLS filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. Cellectis S.A. filed a Form 6-K on November 9, 2026, attaching a press release as Exhibit 99.1. The stock moved +4.7% by the first close after the filing.

Summary of the filing

Cellectis S.A. filed a Form 6-K on November 9, 2026, attaching a press release as Exhibit 99.1. The filing itself contains no substantive details about the press release's contents.

Key details

RegistrantCellectis S.A.
Chief executive officerAndré Choulika

How CLLS stock reacted

Close before

$1.07

Nov 6, 2026

First close after

+4.67%

$1.12

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CLLS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CLLS?

Click here

Frequently asked questions

What did CLLS file with the SEC on Nov 9, 2026?

CLLS filed a 6-K (SEC filing). Cellectis S.A. filed a Form 6-K on November 9, 2026, attaching a press release as Exhibit 99.1. The filing itself contains no substantive details about the press release's contents.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

How did CLLS stock react to this filing?

CLLS closed at $1.07 before the filing and $1.12 on Nov 9, 2026 (+4.67%).

Other CLLS SEC filings

Get alerts when CLLS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days